The loss of bone mass due to the increasing age in women is caused by the decline in ovarian function, known as osteoporosis. Numerous studies have evaluated the benefits of Labisia pumila, but not investigated the OPG/RANKL system. The purpose of the present study was to analyze the effects of L. pumila extract on bone turnover markers and OPG/RANKL system in ovariectomized rats. Totally, twenty-five female Wistar rats were divided into five tgroups (n ¼ 5), including the control group, ovariectomized group, ovariectomized group treated with L. pumila extract of various doses (10 mg/kg; 20 mg/kg and 40 mg/kg). L. pumila extract was administered daily for 8 weeks. Serum levels of osteocalcin, urine levels of deoxypiridinoline, serum levels of OPG and RANKL were analyzed by means of ELISA technique. Serum levels of deoxypiridinoline and urine levels of osteocalcin were significantly higher in the ovariectomized group than those of the control group (p < 0.05). All doses of L. pumila significantly reduced serum levels * Corresponding author. Office address:
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The loss of bone mass due to the increasing age in women is caused by the decline in ovarian function, known as osteoporosis. Numerous studies have evaluated the benefits of Labisia pumila, but not investigated the OPG/RANKL system. The purpose of the present study was to analyze the effects of L. pumila extract on bone turnover markers and OPG/RANKL system in ovariectomized rats. Totally, twenty-five female Wistar rats were divided into five tgroups (n ¼ 5), including the control group, ovariectomized group, ovariectomized group treated with L. pumila extract of various doses (10 mg/kg; 20 mg/kg and 40 mg/kg). L. pumila extract was administered daily for 8 weeks. Serum levels of osteocalcin, urine levels of deoxypiridinoline, serum levels of OPG and RANKL were analyzed by means of ELISA technique. Serum levels of deoxypiridinoline and urine levels of osteocalcin were significantly higher in the ovariectomized group than those of the control group (p < 0.05). All doses of L. pumila significantly reduced serum levels of osteocalcin compared to the ovariectomized group, reaching the levels comparable to those of the control group (p < 0.05). Only the highest dose of L. pumila significantly increased the levels of deoxypiridinoline relative to the ovariectomized and control groups (p < 0.05). The levels of OPG and RANKL and the ratio of OPG/RANKL did not differ significantly among the treatment groups (p > 0.05).
In conclusion, the ethanol extract of L. pumila normalized osteoblastic bone formation, but could not prevent collagen degradation in bone in a rat model of post-menopausal osteoporosis.
© 2018 The Authors. Published by Elsevier Ltd on behalf of European Society for Clinical Nutrition and Metabolism. This is an open access article under the CC BY-NC-ND license (http:// creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
Reduction the bone mass and micro-architectural deterioration that triggering bone fragility and increased risk of fracture is characteristic of osteoporosis [1] . The loss of bone mass due to the increasing age in women is caused by the decline in ovarian function. Pathophysiology of the ovary-related bone loss is complex, and cannot be explained simply by increased bone resorption or decreased bone formation [2] . A bilateral ovariectomy model resembles accelerated bone loss in postmenopausal women, which is constituted by estrogen deficiency [3] . Bilaterally ovariectomized animals show an increase in osteoclastic bone resorption and reactive osteoblastic bone formation with the net result of a loss of bone mass [4] . When the receptor activator of nuclear factor-kappaB ligand (RANKL) expression is more dominant than that of osteoprotegerin (OPG), a progressive bone resorption ensues. When RANKL and OPG expression is comparable or OPG expression is higher than that of RANKL, bone neoformation potentially takes place [5, 6] . In detail, the protective effect of bone by OPG not through induction of bone formation to the normal value or improve the microarchitecture, but through inhibition of bone resorption and increase mineral composition [7e9].
Labisia pumila is a plant with very high phenolic and flavonoid levels. Both of these compounds in the plant are believed to have varied pharmacological activities. In communities of Southeast Asia, decoction of this plant is used as a health supplement to control irregular menstruation and menstrual pain, as well as a tonic to vagina walls after childbirth [10, 11] . Traditionally, L. pumila extracts made by boiling the roots, leaves, or whole parts of the plant are useful to induce labor and metabolic function as an anti-obesity [12] . Numerous studies have evaluated the benefits of L. pumila in a rat model of osteoporosis [11,13e15] , but no research has investigated the OPG/RANKL system. Hence, the purpose of the present study was to analyze the effects of L. pumila extract on bone turnover markers and OPG/ RANKL system in ovariectomized rats.
Material and methods

Subjects
Totally, twenty-five female Wistar rats were acclimatized and randomized to five treatment groups: the control group (sham surgery), the ovariectomized group, ovariectomized group treated with L. pumila extract of various doses (10 mg/kg, 20 mg/kg and 40 mg/kg). The rats were maintained in room temperature (24 C) and 12 h of light and 12 h of dark. In addition, the rats were fed standard laboratory diet and provided with ad libitum access to water.
Procedure for ovariectomy
After acclimatization, the rats performed anesthesia with ketamine (50 mg/kg) and xylacine (8 mg/ kg), bilaterally ovariectomized group were subjected to ventral incision ovariectomy. In addition, five control rats were subjected to sham surgery. Subsequent to ovariectomy, wound care was performed for 10 days and then extract treatment was started [15, 16] .
Preparation of extracts
Preparation of L. pumila extracts was performed according our previous study [15, 17] . The ethanol extract of L. pumila was administered according to the dose using an oral feeding tube to the ovariectomized rats. L. pumila extracts were administered for 8 weeks. Determination of the dose was based on a previous study stating that the dose of L. pumila with no side effect was 50 mg/kg [18] .
Serum and urine collection
At the end of the study, all rats were anesthetized and their blood collected from their hearts by cardiac puncture. Subsequently, the blood was centrifuged to obtain serum. In addition to serum, urine was also collected. Urine was collected by accommodated in metabolic cages. The urine is taken from the urine within 24 h. 
Analysis of bone turnover markers
Analysis of OPG and RANKL
Analysis of the levels of OPG and RANKL was performed on serum using ELISA kits purchased from Elabscience (Wuhan, Hubei, PRC). The analysis was performed according to the detailed procedures set forth in the kit.
Ethics
This study has passed the ethics review of the Ethics Committee, Faculty of Medicine, University of Brawijaya, Malang, East Java, Indonesia.
Statistical analysis
All data were presented in mean ± SD. Differences in levels between treatment groups were analyzed by ANOVA and Least Significance Different using SPSS 16.0 statistical package. A p value of <0.05 was considered statistically significant. In this study, urine levels of deoxypiridinoline were significantly higher in the group of rat model of post-menopausal osteoporosis than those of the control group (p < 0.05). The levels of deoxypiridinoline were significantly higher in all groups of L. pumila treatment than in the control group. Nonetheless, only the highest dose of L. pumila increased the levels of deoxypiridinoline significantly compared to the group of rat model of post-menopausal osteoporosis and the control group (p < 0.05), as seen in Fig. 2 . Table 1 presents the levels of serum OPG, RANKL, RANK: OPG ratio in each experimental group. The levels of OPG and RANKL did not differ significantly among treatment groups (p > 0.05). Besides, the RANK: OPG ratio also did not differ significantly among treatment groups (p > 0.05). 
Results
Discussion
In the present study, serum levels of osteocalcin were significantly higher in the ovariectomized group than those of the control group (p < 0.05). This indicated that approximately nine weeks after ovariectomy in rats, osteoblasts remained acting to form bone as a compensatory mechanism to inhibit the rate of bone loss due to estrogen deficiency. This finding was consistent with those of the previous studies that bilaterally ovariectomized animals showed reactive osteoblastic bone formation characterized by a net result of a loss of bone mass [4] . The increase in the levels of osteocalcin was caused by increased formation of osteoblasts, rather than as a result of increased production by osteoblasts [19] . This finding was in contrast to those of the previous studies showing decreased levels of osteocalcin [14, 20] . This contrast was caused by the ratio of osteocalcin secreted into the blood and bound to the hydroxyapatite crystals [20] . Interestingly, there was no significant difference in the levels of OPG among treatment groups (p > 0.05). This finding indicated that the reactive osteoblasts as a characteristic of osteoporosis due to ovariectomy did not involve an increase in the production of OPG which would inhibit the activation of osteoclasts. Previous studies found no change, increase, or decrease in OPG in the similar experiment [21e24]. In this study, levels of RANKL and the ratio of RANKL: OPG tends to increase in ovariectomy group compared to the control group, although it has not yet reached significant differences. This indicates that the existing mechanism of bone loss, played by RANKL as a trigger differentiation and activation of osteoclasts.
Meanwhile, urine levels of deoxypiridinoline were significantly higher in the ovariectomized group than those of the control group (p < 0.05). Deoxypiridinoline constitutes the cross-linking collagen molecules as a result of post-translational modifications of collagen. Deoxypiridinoline is more specific in bone and not affected by diet or internal metabolism [25] . This marker is a bone resorption marker [26] . This indicated that in ovariectomy bone collagen was degraded to a higher extent than that of the control. This was also in accordance with the characteristics of osteoporosis due to estrogen deficiency, such as an increase in osteoclastic bone resorption [4] . Osteoclastic resorption in this model was not activated by elevated levels of RANKL, but other biofactors [27] .
All doses of L. pumila reduced the serum levels of osteocalcin significantly compared to those of the ovariectomized group, reaching the levels comparable to those of the control group (p < 0.05). This demonstrated that the active components of L. pumila acted through normalizing the reactivecompensating osteoblasts in bone formation to achieve the formation comparable to that of the control group. We also hypothesized that this decrease was caused by the bound to the hydroxyapatite crystals [20] . The findings of the present study were inconsistent with those of the previous studies that found an increase in the levels of osteocalcin due to administration of L. pumila [14] . This contrast was caused by differences in dosage and type of extracts. However, the highest dose of L. pumila increased the levels of deoxypiridinoline significantly compared to those of the ovariectomized group and controls (p < 0.05). This indicated that the higher dose of L. pumila administered to rat model of post-menopausal osteoporosis, may restore osteoblast function to normal, but led to increased bone collagen degradation. We hypothesized that in OVX induced osteoporosis, L. pumila could not prevent collagen degradation in bone. This finding is controversial with that of the previous studies, but with a different marker of bone resorption, the C-terminal telopeptide of type 1 collagen [14] . In this study, the extract L. pumila tend to increase levels of OPG, suppress levels of RANKL, and the ratio of RANKL: OPG, although it has not yet reached significant differences. This indicates that the existing mechanisms of inhibition of bone loss through normalization of OPG and RANKL by active ingredient L. pumila.
